Automated Insulin Delivery Systems for People with Type 2 Diabetes

We introduce a fully automated insulin delivery (AID) system for type 2 diabetes (T2D) patients. This system initially titrates a basal insulin rate for the patient using an I-controller and subsequently introduces a PD-controller for postprandial management. The algorithm is adaptive, ideally allowing it to be applicable to any patient without prior calibration. Additionally, we present a simulation model for T2D patients, combining the existing Hovorka type 1 diabetes (T1D) model and the UVA/Padova T2D model, enabling simulation of T2D patients undergoing exogenous insulin therapy. In a trial with 84 virtual patients simulated using this T2D model, the proposed AID system demonstrated safe and effective titration and treatment, indicating its potential for providing safe and convenient T2D management.

Authors

Institutions

Publication Details

Journal
IFAC-PapersOnLine
Published
2025-01-01
DOI
https://doi.org/10.1016/j.ifacol.2025.06.002
Citations
1
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
1.29
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Automated Insulin Delivery Systems for People with Type 2 Diabetes

Dimitri Boiroux, Henrik Bengtsson, Tinna Björk Aradóttir, John Bagterp Jørgensen et al.
1 citations
IFAC-PapersOnLine
Diabetes Management and Research
1.29
article

Automated Insulin Delivery Systems for People with Type 2 Diabetes

Dimitri Boiroux, Henrik Bengtsson, Tinna Björk Aradóttir, John Bagterp Jørgensen, Ali Mohebbi, Mathilde Guldbæk Arentsen
article en
1 citations

Abstract

We introduce a fully automated insulin delivery (AID) system for type 2 diabetes (T2D) patients. This system initially titrates a basal insulin rate for the patient using an I-controller and subsequently introduces a PD-controller for postprandial management. The algorithm is adaptive, ideally allowing it to be applicable to any patient without prior calibration. Additionally, we present a simulation model for T2D patients, combining the existing Hovorka type 1 diabetes (T1D) model and the UVA/Padova T2D model, enabling simulation of T2D patients undergoing exogenous insulin therapy. In a trial with 84 virtual patients simulated using this T2D model, the proposed AID system demonstrated safe and effective titration and treatment, indicating its potential for providing safe and convenient T2D management.

IFAC-PapersOnLineVol. 59(2)
Novo Nordisk (Denmark) (DK), Regionshospitalet Herning (DK), Technical University of Denmark (DK)
Zero hunger
Openalex Percentile: Top 17%
Diabetes Management and Research
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.